For example, SIRT1 expression was significantly reduced in cancers such as ACC, BLCA, BRCA, CESC, and COAD (p < 0.05), whereas higher expression levels were observed in KIRC, LUAD, and STAD. This evidence concerns the gene SIRT1 and gastric adenocarcinoma.